Factors Determining COVID-19 Third Wave in India

India is gradually re-opening after being hit by the second wave of COVID-19 pandemic but concerns over a possible third wave of COVID-19 pandemic has started.

All India Institute of Medical Sciences (AIIMS) professor highlights the virus-related and human-related factors in predicting the third COVID-19 pandemic wave.

COVID Survivors Still at Risk of Infection from Variants
COVID survivors might get re-infected with SARS-CoV-2 variants as the antibodies tend to decrease over time in some people.

‘COVID-19 protocol and vaccination can prevent the third pandemic wave in India.’

Tweet it Now

Only COVID-19 appropriate behavior can stop these waves as the mutation of the virus is beyond our control. Vaccination will further help in combating the spread of the infection and prevents the severity of disease.

The Delta variant of COVID-19 is infecting people in the United Kingdom in an exponential number when they were planning to reopen the economy made to postpone lifting of lockdown restrictions.

Delta plus variant cases are also reported in India now.

Post-Acute Phase of COVID-19: Fresh Insights
During the post-acute phase of illness, 1 in 7 (14%) adults with coronavirus infection developed at least one new condition that required medical care.

AIIMS Director Randeep Guleria warns the impending COVID-19 third wave may hit India earlier than expected.

"If Covid-appropriate behaviour is not followed, the third wave can happen in six to eight weeks. We need to work aggressively to prevent another large wave till vaccination kicks in," the news agency PTI quoted the senior doctor as saying.

COVID-19 Might Cause Loss of Grey Matter in Brain
A gradual loss of grey matter might occur in COVID survivors, says a recent study.

Though the number of cases showing a downward trend and the positivity rate too shrinking in the last several days, aggressive surveillance strategy should continue.

The moment a significant surge in cases is noted in a particular area and the positivity rate goes beyond 5 per cent, area-specific lockdown and containment measures should be implemented.

Opaganib Helps Treat Moderate-to-severe COVID-19
Opaganib is a medication with potential anticancer, anti-inflammatory, and antiviral activities. It showed excellent efficacy in reducing the need for supplemental oxygen in COVID-19 patients.

Source-Medindia